Arcturus Therapeutics Announces First Quarter 2021 Company Overview and Financial Results and Provides New Clinical Data

Go back to Arcturus Therapeutics Announces First Quarter 2021 Company Overview and Financial Results and Provides New Clinical Data
AMERICAN RCT REIT (NASDAQ: ARCT) Delayed: 7.23 -0.3 (3.98%)
Previous Close $7.53    52 Week High $13.09 
Open $7.59    52 Week Low $5.54 
Day High $7.87    P/E N/A 
Day Low $7.19    EPS $-0.38 
Volume 347,354